Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine
- PMID: 19796606
Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine
Abstract
Inflammation in atherosclerotic plaques causes plaque vulnerability and rupture, leading to thromboembolic complications. Cathepsin B (CatB) proteases secreted by macrophages play a major role in plaque inflammation. We used a CatB-activatable near-infrared fluorescence (NIRF) imaging agent to demonstrate the inflammatory component in mice atheromata and the atherosclerosis- modulating effects of atorvastatin or glucosamine treatments. Apolipoprotein E knockout mice (n = 35) were fed normal chow, a Western diet, a Western diet + atorvastatin, a Western diet + glucosamine, or a Western diet + atorvastatin + glucosamine for 14 weeks. Twenty-four hours after the intravenous injection of a CatB-activatable probe, ex vivo NIRF imaging of the aortas and brains was performed, followed by histology. The CatB-related signal, observed in the aortas but not in the cerebral arteries, correlated very well with protease activity and the presence of macrophages on histology. Animals on Western diets could be distinguished from animals on a normal diet. The antiatherosclerotic effects of atorvastatin and glucosamine could be demonstrated, with reduced CatB-related signal compared with untreated animals. Plaque populations were heterogeneous within individuals, with some plaques showing a high and others a lower CatB-related signal. These differences in signal intensity could not be predicted by visual inspection of the plaques but did correlate with histologic evidence of inflammation in every case. This suggests that vulnerable inflamed plaques can be identified by optical molecular imaging.
Similar articles
-
Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.J Cardiovasc Pharmacol. 2013 Aug;62(2):205-11. doi: 10.1097/FJC.0b013e3182967fc0. J Cardiovasc Pharmacol. 2013. PMID: 23615158
-
In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.Anesthesiology. 2013 Jul;119(1):129-41. doi: 10.1097/ALN.0b013e318291c18b. Anesthesiology. 2013. PMID: 23559030
-
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.Circulation. 2006 Jul 4;114(1):55-62. doi: 10.1161/CIRCULATIONAHA.106.619056. Epub 2006 Jun 26. Circulation. 2006. PMID: 16801460
-
[Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].Turk Kardiyol Dern Ars. 2009 Mar;37 Suppl 2:11-6. Turk Kardiyol Dern Ars. 2009. PMID: 19404045 Review. Turkish.
-
Pleiotropic effects of statins in atherosclerotic disease: focus on the antioxidant activity of atorvastatin.Curr Top Med Chem. 2014;14(22):2542-51. doi: 10.2174/1568026614666141203130324. Curr Top Med Chem. 2014. PMID: 25478882 Review.
Cited by
-
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.Circ Res. 2012 Jul 6;111(2):231-44. doi: 10.1161/CIRCRESAHA.112.268144. Circ Res. 2012. PMID: 22773426 Free PMC article. Review.
-
BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies.Int J Med Sci. 2012;9(5):339-52. doi: 10.7150/ijms.4414. Epub 2012 Jul 1. Int J Med Sci. 2012. PMID: 22811608 Free PMC article.
-
Enzyme-activated probes in optical imaging: a focus on atherosclerosis.Dalton Trans. 2021 Oct 26;50(41):14486-14497. doi: 10.1039/d1dt02198b. Dalton Trans. 2021. PMID: 34605500 Free PMC article. Review.
-
α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol.J Biol Chem. 2016 Feb 5;291(6):2777-86. doi: 10.1074/jbc.M115.669812. Epub 2015 Oct 30. J Biol Chem. 2016. PMID: 26518877 Free PMC article.
-
Near-infrared pH-activatable fluorescent probes for imaging primary and metastatic breast tumors.Bioconjug Chem. 2011 Apr 20;22(4):777-84. doi: 10.1021/bc100584d. Epub 2011 Mar 9. Bioconjug Chem. 2011. PMID: 21388195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical